GlassScriptPhysician profile
Sascha Beaumont
NPI 1689120867
$577.44
in general payments reported to CMS, 2019-2025
10 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.97 · 2023: $191 · 2024: $260 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $560.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $135.73 | 2024 | Nuedexta |
| Neurocrine Biosciences, INC. | $111.72 | 2024-2025 | Ingrezza |
| Abbvie INC. | $72.82 | 2021-2023 | |
| Teva Pharmaceuticals USA, INC. | $60.54 | 2024-2025 | Austedo Xr, Austedo Xr |
| Bayer Healthcare Pharmaceuticals INC. | $53.92 | 2023 | |
| Acadia Pharmaceuticals INC | $47.48 | 2024-2025 | Nuplazid |
| Exact Sciences Corporation | $36.33 | 2023 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.00 | 2023 | Jardiance |
| Abbott Laboratories | $20.25 | 2023 | Freestyle Libre 3 |
| Bioxcel Therapeutics, INC. | $13.65 | 2024 | Igalmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sascha Beaumont listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.